Recently, missense mutations in OPA1 causing decreased protein expression were associated with parkinsonism and cognitive decline,9 suggesting that under certain conditions, loss of OPA1 function may compromise dopaminergic cell viability. Here, OPA1 is linked to Parkinson disease.